Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Structure of the first sphingosine 1-phosphate receptor.
Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis.
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper.
Human T cell expansion and experimental autoimmune encephalomyelitis inhibited by Lenaldekar, a small molecule discovered in a zebrafish screen.
Motor vehicle operation in the setting of multiple sclerosis with myelopathy: assessment, adaptive equipment, counseling, and cessation of driving.
Impact of Repeated Topical-Loaded Manganese-Enhanced MRI on the Mouse Visual System.
Psychiatric symptoms in patients with multiple sclerosis.
Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study.
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.
Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis.
FTY720 is neuroprotective after cuprizone-induced central nervous system demyelination.
Center for Drug Evaluation and Research Approval Letter, application number: 21-897
Comparison of DNA-Hydrolyzing Antibodies from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Humoral mechanisms in T cell vaccination: induction and functional characterization of anti-lymphocytic autoantibodies.
Cost-sharing and initiation of disease-modifying therapy for multiple sclerosis.
Expression and activation of human endogenous retroviruses of the W family in blood cells and astrocytes: implications for the pathogenesis of multiple sclerosis.
Neurofilaments as biomarkers in multiple sclerosis.
Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis.
Cannabinoids control spasticity and tremor in a multiple sclerosis model.
What to expect after natalizumab cessation in a real-life setting.
Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis.
Gray matter involvement in multiple sclerosis.
Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals.
Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort.

Pages